Fundraising FoxStruck Capital Crypto
Venture capitalLos Angeles · Pre-Seed–Series A · 2 people tracked
Find your way into Struck Capital Crypto
Sign up to see every warm intro you have to Struck Capital Crypto
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Struck Capital Crypto team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Fund manager profile
Struck Capital Crypto is a venture fund manager based in Los Angeles. SEC filings show 1 venture fund on record, most recently Struck Capital Fund LP ($25M offering) filed March 2016.
Source: SEC EDGAR Form D filings. Firm website data not yet available.
Team · 2 people
from public directories
Frequently asked questions
- What stage does Struck Capital Crypto invest at?
- Struck Capital Crypto invests at the Pre-Seed, Seed, Series A stages.
- What sectors does Struck Capital Crypto focus on?
- Struck Capital Crypto focuses on Crypto & Web3.
- Where is Struck Capital Crypto located?
- Struck Capital Crypto is headquartered in Los Angeles, US.
Similar investors
AirTree Ventures runs Pathfinders, a free four-week in-person program in Sydney for young builders (high-school graduates up to age 23) to work on a real product, access the AirTree team and founders, and build a peer network.
August Capital is a venture capital firm that invests in a small number of companies, providing hands-on support to entrepreneurs building their businesses.
.jpeg){kind=logo}
B Capital is a global investment firm backing early to late-stage technology innovators across technology, healthcare, and energy & resilience sectors.
Blueyard is a small equal partnership with offices in the US and Europe, investing in early-stage companies.
Breyer Capital is an early-stage, high-conviction investment firm with a dedicated healthcare and life sciences practice backing founders rebuilding medicine at the intersection of science, data, care delivery, and economics.